ATP1A3 and alternating hemiplegia of childhood: Here we report a patient with AHC and a de novo splice-site mutation in ATP1A3 (c.2542 + 1 G > A) who was treated with oral ATP, which decreased the frequency and severity of hemiplegic episodes.